CDM Capital

CDM Capital is an India-based venture and private equity firm with a generalist mandate spanning consumer, B2B software, fintech, and selective healthcare deals. The firm’s positioning is Indian-market-focused, with check sizes and structures that suggest a small-to-mid-cap private capital posture rather than a brand-name VC. Public disclosure of healthcare-specific thesis is limited, so founders should treat them as a generalist Indian investor whose interest in healthcare AI depends on the specific business model and the founders’ direct relationship with the team. Stage focus is most plausibly seed through Series A, with check sizes likely $250K to $2M. For healthcare AI founders, CDM is most credible as a co-investor on Indian software-flavored deals — practice management, RCM, telemedicine, employer health, consumer health products — where the business resembles a SaaS or marketplace company and the regulatory profile is manageable. Founders who should approach: India-based or India-deploying healthcare AI teams with traction, founders looking for an Indian co-investor to fill out a seed or Series A round, and teams with prior commercial relationships in the Indian healthcare ecosystem. Founders who should not approach: regulated medical devices, biotech, and US-only digital health companies. Entry path is warm introduction through the Indian venture network, portfolio CEOs, or co-investors in the regional ecosystem. Their LinkedIn and Crunchbase pages provide partner and portfolio context. Cold outbound is feasible but should be paired with a clear thesis-fit articulation. Be prepared to discuss India-specific go-to-market, regulatory pathways, and unit economics that work at Indian price points.